Trinity Biotech plc (ADR) (NASDAQ:TRIB)
CAPS Rating:
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
Recs
45% growth rate with an unlimited potential...if there is ever an unknown pandemic(praying that this will not be so), TRIB will be a scorcher. BTW: I have owned this stock(bought as a penny stock) for about 8 years and I am waiting for the big bounce which I anticipate in the next year or so. I refuse to sell this one!
Best fundamentals of all the stock I bought before the Bubble burst...only one still invested. Catch it if it falls blow $9 then hold for retirement(I hope).